Montage (688008) Report Interpretation

Overview

Goldman Sachs reviews Montage's in-line 2Q26 results and maintains Buy. The report argues that DDR5/DDR6 migration and a broadening AI-related interconnect portfolio should support growth, while recognizing near-term gross-margin pressure and a slower-than-expected CKD ramp-up.

Core views

Montage reported 2Q26 revenue of Rmb1.875bn, up 28% quarter on quarter and 33% year on year, in line with Goldman Sachs estimates, company guidance, and consensus. Net income was Rmb1.150bn, up 36% quarter on quarter and 81% year on year, while diluted EPS of Rmb0.94 was 3% above Goldman Sachs' Rmb0.92 estimate. The result was driven by the ramp-up of DDR5 interface ICs and growth in newer products including MRCD/MDB, PCIe Retimer, CKD and CXL MXC. The principal shortfall was profitability: gross margin was 61.8%, below Goldman Sachs' 67.1% forecast and 66.6% consensus, which management attributed to product-mix changes. The report's central growth thesis is continued migration to higher-generation memory interfaces. DDR5 Gen 3 and Gen 4 products accounted for more than 50% of RCD shipments in 1H26, and DDR5 Gen 5 has entered volume shipment. Montage sampled DDR5 Gen 6 in June and is conducting R&D for DDR6 Gen 1. Goldman Sachs relays management's view that AI inference raises the importance of CPUs and memory channels per CPU, increasing demand for memory modules and therefore interconnect IC content. Newer products are an additional, later-stage growth driver. Revenue from MRCD/MDB, PCIe Retimer, CKD and CXL MXC was Rmb538mn in 1H26, up 81% year on year, led by PCIe Retimer and CKD chips. Management expects MRCD/MDB to begin a meaningful volume ramp in 2027E as supporting CPU platforms and ecosystems mature. Montage is preparing PCIe 6.x Retimer for volume production in 2027 and is working toward 2H26E engineering samples for PCIe 7.0 Retimer, PCIe Switch and high-speed Ethernet PHY Retimer. Goldman Sachs incorporates the quarter and lowers 2026E-2032E earnings estimates by about 2%. The main reason is lower CKD revenue assumptions because its ramp is taking longer than expected; the firm also lowers gross-margin assumptions to reflect cost pressure. Even so, it remains constructive on the incremental contribution from innovative-product revenue over time. Following the estimate changes, Goldman Sachs lowers its 12-month A-share target price to Rmb380 from Rmb387 and its H-share target to HK$572 from HK$583, while maintaining Buy. The A-share target uses a 48.1x 2030E discounted P/E, versus 48.0x previously, with the multiple derived from peers' P/E and net-income-growth correlation. The H-share target uses 66.4x 2030E P/E, versus 66.2x previously, representing a 38% valuation premium to the A share and using CNY/HKD of 1.09. The stated prices of Rmb213.00 for the A share and HK$285.00 for the H share imply upside of 78.4% and 100.7%, respectively.

Analysis framework

Goldman Sachs first compares quarterly revenue, earnings and margins with its estimates, management guidance and consensus. It then evaluates the product-generation roadmap and new-product ramp timing, revises revenue and margin assumptions, and applies discounted forward P/E multiples informed by peer valuation and net-income-growth correlation to set 12-month targets.

Methodology notes

• Valuation methodsP/E and PEG Valuation

  Discounted P/E valuation based on peer P/E and net-income-growth correlation.

  The report applies 2030E P/E multiples to estimate 12-month A- and H-share targets, using peer valuation and expected earnings growth to anchor the selected multiples.

• Industry AnalysisUpstream-Midstream-Downstream Transmission

  CPU and memory-channel growth in AI inference increases memory-module and interconnect-IC content.

  The report links AI-inference platform requirements and maturing CPU ecosystems to demand for Montage's memory-interface and adjacent interconnect products.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Montage (A) (688008.SS)

  Primary covered A-share security; expected to benefit from DDR5/DDR6 migration and innovative-product growth.

  Strengths

  Leading position in memory interconnect ICs and expanding AI interconnect portfolio.

  Weaknesses

  2Q26 gross margin was below estimates because of product-mix changes.

  Comparison

  Target uses a 48.1x 2030E discounted P/E derived from peers' P/E and net-income-growth correlation.

  Risks

  Weaker memory-interface market growth, slower new-product introductions, or fiercer competition.

• Montage (H) (6809.HK)

  Primary covered H-share security representing the same company exposure.

  Strengths

  Shares the company's memory-interface and AI interconnect growth drivers.

  Weaknesses

  Subject to the same slower CKD ramp and margin-pressure assumptions.

  Comparison

  Target uses a 66.4x 2030E P/E, a 38% premium to the A-share valuation.

  Risks

  Weaker memory-interface market growth, slower new-product introductions, or fiercer competition.

Key data

• 2Q26 revenueRmb1.875bnUp 28% QoQ and 33% YoY; in line with Goldman Sachs estimates, guidance and consensus.
• 2Q26 net incomeRmb1.150bnUp 36% QoQ and 81% YoY.
• 2Q26 gross margin61.8%Below Goldman Sachs' 67.1% estimate and 66.6% consensus; management cited product-mix changes.
• 1H26 innovative-product revenueRmb538mnUp 81% YoY, driven by PCIe Retimer and CKD chips.
• Earnings revisionAbout -2% for 2026E-2032EPrimarily reflects lower CKD revenue assumptions and lower gross-margin assumptions.
• A-share target priceRmb380.00Based on 48.1x 2030E discounted P/E; stated upside is 78.4%.
• H-share target priceHK$572.00Based on 66.4x 2030E P/E; stated upside is 100.7%.

Impact & implications

The report views the near-term margin miss and slower CKD ramp as manageable relative to the longer-term opportunity from DDR5/DDR6 migration and expanding AI interconnect products. Its maintained Buy rating reflects this positive longer-term product and content-growth outlook despite reduced estimates and target prices.

Risks

• Memory interface IC market growth could be weaker than expected.
• New product introductions could progress more slowly than expected.
• Market competition could become fiercer than expected.

What to watch

• The pace of DDR5 Gen 5 volume shipments and progress toward DDR5 Gen 6 and DDR6 Gen 1.
• Whether MRCD/MDB begins meaningful volume ramp-up from 2027E as CPU platforms and ecosystems mature.
• Execution on PCIe 6.x Retimer volume production in 2027 and 2H26E engineering samples for PCIe 7.0 Retimer, PCIe Switch and Ethernet PHY Retimer.
• CKD revenue ramp timing and gross-margin trends amid cost pressure and product-mix changes.